Hot Flashes During Perimenopause

Written by Dr. Fiona McCulloch, ND, FABNE — naturopathic doctor with a clinical focus in hormonal health and over 25 years of clinical experience.

Understanding Why They Happen and How They Are Treated

Hot flashes are one of the most common reasons women seek support during perimenopause — and one of the most disruptive. They can affect sleep, concentration, work, and daily functioning. But hot flashes during perimenopause are not the same as hot flashes after menopause. In perimenopause, hot flashes are often driven by estrogen volatility — dramatic fluctuations in estrogen levels — rather than the simple estrogen deficiency that characterizes post-menopause. This distinction is clinically important because it changes how treatment is approached. At White Lotus Clinic’s menopause and perimenopause program in Toronto, hot flashes treatment begins with understanding what is driving the symptoms in each individual patient.

If hot flashes are affecting your daily life, a consultation can help clarify what’s driving them and what options are available.

When Hot Flashes Become More Than a Minor Inconvenience

Approximately 80% of women experience hot flashes during the menopausal transition. For many, they are manageable — mild, infrequent, and short-lived. But for a significant number of women, hot flashes are substantially disruptive. In clinical practice, patients describe not sleeping well because of the hot flashes, waking up with brain fog, feeling very restless at night. Some describe having severe hot flashes at work — having to leave the room, having to change their clothes, covered in sweat. The range of severity is wide, and the impact on daily functioning can be considerable.

Many women have already tried over-the-counter supplements from the drugstore or health food store with limited success. Some have had negative experiences with birth control — side effects, mood changes, or even hot flashes triggered by hormonal contraceptives — and are now understandably cautious about any hormonal approach. Others have been told by their family doctor that hot flashes are just part of menopause and will pass on their own. If any of this sounds familiar, you are not alone — and there are options beyond what you may have already tried.

For many patients, the point at which they seek clinical support is when hot flashes are destroying their sleep. When you cannot sleep, you cannot work, nothing else goes well — there are mood changes, cognitive difficulty, and a cumulative effect on daily life. Sleep disruption from hot flashes is a clinically recognized presentation, and it is one of the most common reasons patients seek assessment.

Minimalist pink background with folding hand fan, menopause-themed visual

Why Perimenopause Hot Flashes Require a Different Approach

Most hot flashes content — and many treatment protocols — treat all hot flashes identically. But hot flashes during perimenopause are driven by estrogen volatility: dramatic spikes and crashes in estrogen levels as the ovaries fluctuate between high output and low output. This is fundamentally different from post-menopausal hot flashes, which are driven by sustained estrogen deficiency. In perimenopause, progesterone often plays a regulatory role — helping to modulate the estrogen fluctuations that trigger vasomotor symptoms — while estrogen therapy may be considered strategically based on specific clinical indicators. An individualized assessment is essential because every patient’s hormonal picture is different.

If a previous experience with hormones was negative — whether that was side effects from a standard HRT protocol, or a reaction to hormonal birth control — it does not necessarily mean that hormonal support is not appropriate. In many cases, the issue is in the protocol itself: the formulation, the dose, the route of administration, or the timing. A different approach, individualized to the specific presentation, can yield a different experience. At White Lotus Clinic, the assessment is designed to evaluate what is happening in each patient’s case before recommending any treatment pathway.

What Causes Hot Flashes During Perimenopause

Hot flashes are a thermoregulatory event. Estrogen plays a role in regulating the hypothalamic thermoneutral zone — the range of core body temperatures that the brain considers normal. When estrogen levels fluctuate, this thermoneutral zone narrows. A small increase in core body temperature that would previously go unnoticed now triggers the brain’s cooling response: blood vessels near the skin dilate rapidly (the hot flash), followed in some cases by sweating, chills, or both.

In perimenopause, estrogen does not decline in a predictable, linear way. Instead, it fluctuates — sometimes spiking to levels higher than pre-menopausal baseline, then dropping sharply. Some patients are very sensitive to these fluctuations. This pattern of volatility is what distinguishes perimenopause hot flashes from post-menopausal hot flashes, where estrogen levels are consistently low.

During perimenopause, the ovaries are still producing hormones — but the production is unstable. Estrogen spikes and crashes. Progesterone is often the first hormone to decline, and in this phase it is often significantly deficient. After menopause, ovarian hormone production is minimal, and the primary issue is sustained deficiency rather than volatility. This distinction matters for treatment: the approach that works for post-menopausal deficiency is not necessarily the same approach that addresses perimenopause volatility.

Clinically, there are patterns in how hot flashes present. Patients who had high estrogen levels throughout their lives tend to experience more severe hot flashes during perimenopause — though this is a clinical observation, not a rule. Perimenopause itself is tumultuous: hot flashes can appear for a period, recede, and then return, because the body can still produce estrogen intermittently. Women who enter perimenopause at a younger age may experience hot flashes for a longer period of time. Hot flashes can also suggest broader changes in estrogen levels — patients with significant hot flashes may also experience metabolic shifts, vaginal dryness, or changes in sexual function.

Treatment Options for Hot Flashes in Perimenopause

Treatment for hot flashes depends on each individual patient. The assessment considers risks versus benefits, family history, past experiences with hormones or supplements, and what the patient is looking for — whether they want high efficacy quickly or are comfortable with a more gradual approach. Everyone is different, and treatment can start with any approach the patient prefers. White Lotus Clinic offers the full spectrum, from botanical and non-hormonal approaches through to bioidentical hormone prescribing.

Non-Hormonal and Botanical Approaches

For patients who prefer to start without hormones — or who are exploring a gradual approach — there are clinically relevant non-hormonal options. These are not the same as over-the-counter supplements from a drugstore. In clinical practice, botanical protocols use specific herbs at therapeutic dosages: Siberian rhubarb, black cohosh, sage, and phytoestrogens such as red clover are among the options considered, depending on the patient's presentation. Dietary and lifestyle modifications also play a role. It is important to have realistic expectations: botanical approaches can take up to two months to show their full effect, and results vary between patients.

Progesterone in Perimenopause

Progesterone is often the first hormone to decline in perimenopause — it is often significantly deficient during this phase. Research from Dr. Jerilynn Prior at the Centre for Menstrual Cycle and Ovulation Research (CeMCOR) at the University of British Columbia has shown that progesterone works directly on vasomotor symptoms — not only as a secondary benefit. Clinically, estrogen remains the primary hormone for hot flash relief, but in some patients — especially those in perimenopause — progesterone can help. It depends on the type of hot flash and the intensity. For some patients, progesterone alone is sufficient. For those with severe, intense hot flashes, both hormones are usually needed. Ontario naturopathic doctors have prescribing authority for bioidentical progesterone.

Learn more about cyclic progesterone therapy and how it is used in perimenopause.

When Estrogen Is Considered

Estrogen is added to the treatment plan whenever there are signs of sustained low estrogen — persistent hot flashes, vaginal dryness, or non-responsiveness to progesterone alone. Patients who have longer intervals between their periods are more likely to have periods of low estrogen. Hormone testing through spot tests can help identify patterns, though it is not essential — symptom patterning and menstrual cycle history often correlate with the overall hormonal picture. In some patients, estrogen can be considered from the outset, depending on their presentation. An important clinical reframe: in perimenopause, endogenous estrogen levels are often significantly higher than the estrogen doses used in hormone replacement therapy. In some cases, providing a steady low dose of estrogen through HRT can actually reduce the high spikes of endogenous estrogen — so the net estrogen exposure may not increase.

The safety conversation around hormone therapy has changed substantially since the early studies that created widespread concern. Those original studies used high doses of oral estrogen combined with synthetic progestins — a very different formulation and delivery route than what is used in modern bioidentical hormone therapy. Oral estrogen passes through the liver and is converted into metabolites that can remain elevated in the blood for extended periods — these metabolites are associated with an increased risk of blood clots. The same liver-mediated pathway applies to oral contraceptive pills. Transdermal estrogen — delivered through the skin — does not pass through the liver in the same way and does not produce these clotting metabolites. Research has not demonstrated an increased risk of breast cancer with transdermal estrogen. When natural progesterone is used instead of synthetic progestins, the risk profile changes further: natural progesterone has never been shown to cause blood clots and may have protective actions with respect to breast tissue.

For patients whose negative experience with birth control is part of what makes them cautious about hormones: birth control pills use oral estrogen, which follows the liver-mediated pathway described above. Bioidentical hormone therapy uses transdermal estrogen, which follows a fundamentally different metabolic route. A negative experience with oral contraceptives does not predict the experience with transdermal hormone therapy. The formulations, the delivery, and the physiological effects are different.

That said, hormones can feed cancers if they develop incidentally — regardless of the delivery route. This is why it is important to follow all breast screening guidelines recommended for your age range.

Read more about bioidentical hormone therapy safety updates.

A realistic treatment timeline: with hormonal approaches, most patients notice a reduction in hot flash frequency and intensity within two weeks to one month. With botanical and supplement-based approaches, improvement can take longer — sometimes up to two months. These are general clinical observations, not guarantees, and individual responses vary.

Night Sweats and Sleep Disruption in Perimenopause

Night sweats are the nocturnal expression of the same thermoregulatory mechanism that causes daytime hot flashes. They directly disrupt sleep through repeated awakenings — and the cumulative effect of night after night of broken sleep is significant. Patients describe brain fog, difficulty concentrating, mood changes, and a general sense that daily functioning has deteriorated. In clinical practice, sleep disruption from night sweats is the single most common factor that drives patients to seek assessment.

Progesterone has particular relevance for patients whose primary complaint is sleep disruption from night sweats. Beyond its role in reducing vasomotor symptom frequency and intensity, progesterone is metabolized into allopregnanolone — a neurosteroid that modulates GABA-A receptors and promotes sleep. This means progesterone can address both the hot flash itself and the sleep disruption through different physiological pathways.

For more on this topic, read about progesterone for sleep during menopause.

What Triggers Hot Flashes

  • Alcohol
  • Caffeine
  • Spicy food
  • Stress and emotional intensity
  • Warm environments and overheating
  • Tight or layered clothing

Awareness of common triggers can help manage hot flashes alongside clinical treatment — though trigger avoidance alone is generally not sufficient to resolve significant vasomotor symptoms.

Hot flashes rarely occur in isolation. They tend to suggest that the patient has more of a loss of estrogen overall, which may also be associated with metabolic changes, vaginal dryness, and changes in sexual function. Perimenopause can change every single hormone in the body — and a comprehensive assessment evaluates the broader hormonal and metabolic picture, not just the hot flashes themselves.

Estriol for vaginal and urinary symptoms · Muscle and joint pain during menopause · Menopause and perimenopause program

Hot flashes can also occur in the context of thyroid conditions — hypothyroidism, for example, is sometimes linked to high estrogen patterning, which can set the stage for vasomotor symptoms. Certain medications can trigger or worsen hot flashes. Other hormonal complexities — including PCOS entering the perimenopause transition — always warrant a full investigation of the entire hormone picture, because perimenopause can affect hormonal systems beyond estrogen and progesterone. Hormone testing can help identify contributing factors, though clinical symptom patterning is also informative.

PCOS and perimenopause · How cortisol and estrogen interact

 

Frequently Asked Questions About Hot Flashes in Perimenopause

Why do hot flashes happen during perimenopause?

Hot flashes are a thermoregulatory response triggered by fluctuations in estrogen levels. Estrogen plays a role in regulating the brain’s temperature control centre. During perimenopause, estrogen does not decline steadily — it spikes and crashes. These fluctuations narrow the range of body temperatures the brain considers normal, so even small changes in core temperature can trigger a hot flash. This volatility pattern is different from post-menopause, where hot flashes are driven by sustained estrogen deficiency.

Research from the Study of Women’s Health Across the Nation (SWAN) found that the median duration of vasomotor symptoms is approximately 7.4 years, with a range from about 1 year to over 14 years. Earlier onset of symptoms tends to correlate with longer duration. Perimenopause is a tumultuous phase — hot flashes can appear, recede, and return because the body can still produce estrogen intermittently. Women who enter perimenopause at a younger age may experience hot flashes for a longer period.

Research from Dr. Jerilynn Prior at the Centre for Menstrual Cycle and Ovulation Research (CeMCOR) at the University of British Columbia has shown that progesterone works directly on vasomotor symptoms. Progesterone is often the first hormone to decline in perimenopause and is frequently significantly deficient during this phase. Clinically, the response to progesterone depends on the type and intensity of the hot flash — for some patients, progesterone alone is sufficient, while patients with severe hot flashes often need both progesterone and estrogen. Learn more about cyclic progesterone therapy.

The safety profile of hormone therapy depends on the route of administration and the type of hormone used. The studies that originally raised concern about HRT used high doses of oral estrogen combined with synthetic progestins. Oral estrogen passes through the liver and produces metabolites associated with blood clot risk. Transdermal estrogen — delivered through the skin — does not follow this liver pathway and has not been shown to carry the same clotting risk. Research has not demonstrated an increased risk of breast cancer with transdermal estrogen. Natural progesterone, unlike synthetic progestins, has never been shown to cause blood clots. However, hormones can feed cancers if they develop incidentally — following all recommended breast screening guidelines is important regardless of the type of hormone therapy used.

Read more about bioidentical hormone therapy safety updates.

During perimenopause, the ovaries are still producing hormones — but production is unstable. Estrogen levels spike and crash, and progesterone is often significantly deficient. Hot flashes during this phase are driven by this volatility. After menopause, ovarian hormone production is minimal and hot flashes are driven by sustained estrogen deficiency. This distinction affects treatment: in perimenopause, progesterone often plays a regulatory role in modulating estrogen fluctuations, while estrogen therapy may be added based on specific clinical indicators.

Birth control pills use oral estrogen, which passes through the liver and follows a metabolic pathway that can produce side effects including blood clots, mood changes, and — in some cases — hot flashes. Bioidentical hormone therapy typically uses transdermal estrogen, which is delivered through the skin and follows a fundamentally different metabolic route. It does not pass through the liver in the same way. Additionally, the progesterone used in bioidentical HRT is natural progesterone — a different compound from the synthetic progestins found in many birth control formulations. A negative experience with oral contraceptives does not predict the experience with transdermal bioidentical hormone therapy.

Hot flashes are associated with the menopausal transition, and they do eventually resolve as hormonal levels stabilize after menopause. However, the timeline varies widely — SWAN data shows a range from about 1 year to over 14 years, with a median of 7.4 years. During perimenopause, hot flashes can come and go unpredictably because the body is still capable of producing estrogen intermittently. Clinical treatment can help manage symptoms during this transitional period.

The assessment begins with a comprehensive clinical history. We review all of the clinical symptoms: sleep quality, menstrual cycle patterns, whether hot flashes occur during the day or at night, and other symptoms that may be related — such as signs of high estrogen like heavy periods, or histamine-related patterns. Hormone testing through spot blood tests is available and can help identify hormonal patterns, though it is not essential — in many cases, the patterning of periods and symptoms correlates well with the overall hormonal picture. From there, treatment options are reviewed across the full spectrum: non-hormonal approaches including botanical protocols, progesterone, estrogen, or combination approaches. The discussion always includes risks versus benefits, family history, and what the patient is looking for. The first visit is a detailed clinical conversation that results in an individualized plan.

What Your First Visit Looks Like

1

Comprehensive clinical history

We review sleep quality, menstrual cycle patterns and timing, symptom history, family history, and any past experiences with hormones or supplements.

2

Hot flash assessment

We evaluate whether hot flashes occur during the day, at night, or both; their frequency and intensity; and whether there are associated symptoms such as signs of high estrogen (heavy periods) or histamine-related patterns.

3

Hormone testing, if appropriate

Spot hormone tests can help identify hormonal patterns. Testing is helpful but not essential — symptom patterning and menstrual cycle history also provide clinically useful information.

4

Treatment options discussion

The full spectrum is reviewed: non-hormonal and botanical approaches, progesterone, estrogen, or combination approaches. This discussion always includes risks versus benefits and is guided by what the patient is looking for.

5

Individualized treatment plan

Everyone is different. The plan is built around the patient's specific presentation, preferences, and goals.

If you have been prescribed a standard protocol before — one that did not account for your individual presentation — this assessment is designed to evaluate your specific situation rather than apply a one-size-fits-all approach.

Meet our Practitioners

Both Dr. Fiona and Dr. Alex see PCOS patients at White Lotus Clinic using the same clinical framework. Fees differ by practitioner.

Fees for Dr Alexandra Triendl-Dimitriu, ND

Perimenopause care using the same clinical framework as Dr. Fiona. For complex or challenging cases, Dr. Alex has direct access to Dr. Fiona's guidance — so you benefit from that depth of expertise regardless of which practitioner you see.

TimeDescriptionPrice
Up to 90 minsInitial Naturopathic Consultation$350
30mFollowup Naturopathic Consultation$110

Fees for Dr Fiona McCulloch, RAc, ND

Author of 8 Steps to Reverse Your PCOS. Treating Menopause for 20+ years with a clinical focus in hormonal health, thousands of patients assessed.

TimeDescriptionPrice
Up to 90 minInitial Naturopathic Consultation$420
45mFollowup Naturopathic Consultation$215

Click Links in description to see booking options. All new patents must start with an initial consultation.

Insurance Coverage
Insurance is not provided by OHIP but is typically included on most extended insurance plans.

Prescribing note

Both practitioners are licensed naturopathic doctors in Ontario with prescribing authority for bioidentical hormones, cyclic progesterone and natural dessicated thyroid medication. Prescribed medications may be covered by your prescription drug insurance.

Getting here

Location

121 Willowdale Ave Suite 301
Toronto / North York, Ontario M2N 6A3
Located near Yonge & Sheppard.

View on Google Maps →

Clinic Hours

Monday9:00 AM – 5:00 PM
Tuesday9:00 AM – 5:00 PM
Wednesday9:00 AM – 5:00 PM
Thursday9:00 AM – 7:00 PM
Friday9:00 AM – 5:00 PM
Saturday9:00 AM – 4:30 PM
SundayClosed

Located in North York, Toronto. 

Transit and parking:
3-minute walk from Sheppard–Yonge Station
3 minute drive from the Highway 401 Bayview exit by car
Street parking available 

Accessibility:
Elevator access
Entrance Ramp
Please contact us if accommodations are needed.

Serving Our Community:
We provide registered acupuncture care to patients across North York, including Willowdale, Lansing, Newtonbrook, Bayview Village, and the Greater Toronto Area.

Hot flashes during perimenopause can persist for years — research shows a median duration of 7.4 years. Treatment response with hormonal approaches, by contrast, is typically measured in weeks: most patients notice a meaningful change within two weeks to one month. With non-hormonal approaches, improvement may take up to two months. The gap between how long the symptoms can last and how quickly treatment can take effect is worth understanding when considering your options.

When treatment is working well, patients often describe a shift that goes beyond the hot flashes themselves. They describe being able to sleep through the night again. The most common thing patients say is that they feel like themselves again — that the disruption is over, and they can function and get back to everything they need to do. For many patients, managing hot flashes is about reclaiming daily life.

Explore Your Options

If hot flashes are affecting your sleep, your work, or your daily life, a consultation through our menopause and perimenopause program can help clarify what is happening and what options are available. The first visit is a detailed clinical assessment — we review your symptoms, history, and goals before discussing treatment. You will understand where you stand and what your options are.

Book a Consultation

Or call (416) 730-8218